Cyclobenzaprine Hcl
Brand name: Cyclobenzaprine Hcl
Rank #348 of 500 drugs by total cost
$28.7M
Total Cost
2,582,519
Total Claims
$28.7M
Total Cost
68,944
Prescribers
$11
Cost per Claim
779,077
Beneficiaries
3,129,348
30-Day Fills
$417
Avg Cost/Provider
37
Avg Claims/Provider
About Cyclobenzaprine Hcl
Cyclobenzaprine Hcl (sold as Cyclobenzaprine Hcl) was prescribed 2,582,519 times by 68,944 Medicare Part D providers in 2023, costing the program $28.7M. At $11 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 345 | Esketamine Hcl (Spravato) | $29.0M | 20,816 |
| 346 | Warfarin Sodium (Warfarin Sodium) | $28.9M | 2,126,832 |
| 347 | Ivosidenib (Tibsovo) | $28.9M | 931 |
| 348 | Cyclobenzaprine Hcl (Cyclobenzaprine Hcl) | $28.7M | 2,582,519 |
| 349 | Atenolol (Atenolol) | $28.6M | 2,717,988 |
| 350 | Meloxicam (Meloxicam) | $28.6M | 4,714,084 |
| 351 | Triamcinolone Acetonide (Triamcinolone Acetonide) | $28.5M | 2,307,130 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology